id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-344198-jaagi88b	Eimer, J.	Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID‐19: a retrospective cohort study	2020-08-18		.txt	text/plain	1517	77	41	Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID-19: a retrospective cohort study Dear Editor, Amongst patients with COVID-19 who require treatment in intensive care for acute respiratory distress syndrome (ARDS), mortality rates have been reported between 16 and 78% [1] . Patients over 18 years with confirmed SARS-CoV-2 infection were eligible when admitted to the intensive care unit (ICU) for severe ARDS and were followed for 30 days from admission to ICU until discharge from hospital or until death, whichever occurred first. In this retrospective cohort study, the administration of tocilizumab did not reduce all-cause mortality but was associated with a shorter time on mechanical ventilation and a shorter length of stay in hospital and in ICU in critically ill patients with ARDS due to COVID-19.	./cache/cord-344198-jaagi88b.txt	./txt/cord-344198-jaagi88b.txt